Given the extent of disagreement among observers regarding the color of infants observed under identical conditions (i.e., via video recording), the study authors concluded that real-world visual ...

About a year after beginning its full market launch, Masimo’s W1 smartwatch can now be used as a medical device in the U.S. The wearable device has earned FDA clearance for its medical applications, ...

Acknowledging the disparity in pulse oximetry implicates a $2 billion industry that has faced stricter regulations in recent years in an attempt to address bias in the development and testing of these ...

Blood oxygen measurements taken with pulse oximeters in hospitals tend to be lower than they really are, according to the Equiox study, which was designed to assess the technology’s measurement ...

Masimo, a global medical technology company, announced the results of a study published in Pneumonia in which independent researchers in New Delhi, India, investigated the accuracy of Masimo RRp on ...

About a week after the FDA convened its latest meeting to discuss strategies for reducing racial biases in widely available pulse oximetry technology, Masimo has released new study data suggesting ...

The U.S. Food and Drug Administration is seeking public comment on new recommendations for nonclinical and clinical performance testing to support premarket submissions for pulse oximeters for medical ...